Drug profile · INN
pneumococcal saccharide conjugated vaccine, adsorbed
PREVENAR
pneumococcal saccharide conjugated vaccine, adsorbed (PREVENAR) is a immunostimulant.
EMA: withdrawn Antiinfectives for systemic use (J07) J07AL02
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — pneumococcal saccharide conjugated vaccine, adsorbed
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.83
Quick answer
pneumococcal saccharide conjugated vaccine, adsorbed (PREVENAR) is a immunostimulant.
Key facts
INN pneumococcal saccharide conjugated vaccine, adsorbed
Brand PREVENAR
Mechanism Immunostimulant
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07AL02
Mechanism of action
Immunostimulant
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is pneumococcal saccharide conjugated vaccine, adsorbed?
pneumococcal saccharide conjugated vaccine, adsorbed (PREVENAR) is a immunostimulant.
What is the brand name for pneumococcal saccharide conjugated vaccine, adsorbed?
PREVENAR is a marketed brand name for pneumococcal saccharide conjugated vaccine, adsorbed. Check FDA Drugs@FDA for the current US label holder and prescribing information.